Quantitative imaging biomarkers of immune-related adverse events in immune-checkpoint blockade-treated metastatic melanoma patients: a pilot study

PURPOSE: To develop quantitative molecular imaging biomarkers of immune-related adverse event (irAE) development in malignant melanoma (MM) patients receiving immune-checkpoint inhibitors (ICI) imaged with (18)F-FDG PET/CT. METHODS: (18)F-FDG PET/CT images of 58 MM patients treated with anti-PD-1 or...

Descripción completa

Detalles Bibliográficos
Autores principales: Hribernik, Nežka, Huff, Daniel T, Studen, Andrej, Zevnik, Katarina, Klaneček, Žan, Emamekhoo, Hamid, Škalic, Katja, Jeraj, Robert, Reberšek, Martina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9016045/
https://www.ncbi.nlm.nih.gov/pubmed/34958422
http://dx.doi.org/10.1007/s00259-021-05650-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9016045/
https://www.ncbi.nlm.nih.gov/pubmed/34958422
http://dx.doi.org/10.1007/s00259-021-05650-3

Ejemplares similares